C. Nonsteroidal antiinflammatory drugs (NSAIDs) (iburprohen can reduce the effect of ACE and predispose the pt. with acute renal failure); other adverse effects: potassium levels above 5 mEq/L because they promote hyperkalemia, lactating women, children, bilateral renal disease); rash, pruritus, anemia, neutropenia, thrombocytosis, and agranulocytosis.